<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40925721</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Safety and efficacy of personalised delayed anticoagulation for reducing perioperative blood loss in total knee arthroplasty patients: protocol for a randomised controlled trial.</ArticleTitle><Pagination><StartPage>e092640</StartPage><MedlinePgn>e092640</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e092640</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2024-092640</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The management of bleeding and coagulation after total knee arthroplasty (TKA) has long been recognised as a significant challenge for orthopaedic surgeons. Despite the notable success of empirical anticoagulation in preventing venous thromboembolism (VTE) following TKA, the increased risk of postoperative bleeding has also raised extensive concern. Ecchymosis, as one of the most common manifestations indicating postoperative bleeding, holds the potential to indicate the balance of bleeding and hypercoagulation. However, there is still a lack of evidence-based medical research to determine the importance of postoperative ecchymosis and related personalised anticoagulation therapy. Therefore, we have designed a randomised controlled trial aimed at assessing the safety and efficacy of personalised delayed anticoagulation strategies in the management of postoperative bleeding in TKA patients.</AbstractText><AbstractText Label="METHODS AND ANALYSIS" NlmCategory="METHODS">This is a prospective, randomised, controlled trial. Patients diagnosed with end-stage knee osteoarthritis will be grouped based on the presence of ecchymosis after TKA. Those without ecchymosis will receive standard anticoagulation therapy, while those with ecchymosis will be randomised in a 1:1 ratio into either the standard anticoagulation group or the delayed anticoagulation group. The primary outcomes will compare the blood routine examination, coagulogram, thromboelastography and the incidence of VTE. The secondary outcomes will include surgical-related complications. Additionally, patient baseline data and surgery-related data will also be recorded and analysed.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">Ethics approval has been obtained from The First Affiliated Hospital of Chongqing Medical University (2024-194-01). The results will be disseminated at international conferences and in peer-reviewed publications.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ChiCTR2400084440.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Luo</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kang</LastName><ForeName>Runxing</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yinsong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Mingfei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-9116-2985</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China liaojunyi@cqmu.edu.cn huangwei68@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Junyi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0009-1338-3091</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China liaojunyi@cqmu.edu.cn huangwei68@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020370" MajorTopicYN="Y">Osteoarthritis, Knee</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="Y">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004438" MajorTopicYN="N">Ecchymosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="Y">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult orthopaedics</Keyword><Keyword MajorTopicYN="N">Anticoagulation</Keyword><Keyword MajorTopicYN="N">Bleeding disorders &amp; coagulopathies</Keyword><Keyword MajorTopicYN="N">Knee</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>10</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>10</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>9</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40925721</ArticleId><ArticleId IdType="pmc">PMC12421601</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2024-092640</ArticleId><ArticleId IdType="pii">bmjopen-2024-092640</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeFrancesco CJ, Reichel JF, Gbaje E, et al. Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial. Br J Anaesth. 2023;130:234&#x2013;41. doi: 10.1016/j.bja.2022.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.11.003</ArticleId><ArticleId IdType="pmc">PMC9900725</ArticleId><ArticleId IdType="pubmed">36526484</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller L, Pijnenburg L, Idoux-Gillet Y, et al. Preclinical safety study of a combined therapeutic bone wound dressing for osteoarticular regeneration. Nat Commun. 2019;10:2156. doi: 10.1038/s41467-019-10165-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10165-5</ArticleId><ArticleId IdType="pmc">PMC6517440</ArticleId><ArticleId IdType="pubmed">31089136</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo BJX, Koh JSB, Jiang L, et al. Association of the 36-Item Short Form Health Survey Physical Component Summary Score With Patient Satisfaction and Improvement 2 Years After Total Knee Arthroplasty. JAMA Netw Open. 2019;2:e190062. doi: 10.1001/jamanetworkopen.2019.0062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.0062</ArticleId><ArticleId IdType="pmc">PMC6484598</ArticleId><ArticleId IdType="pubmed">30794301</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Kallan MJ, Chen Y, et al. Association of Race/Ethnicity With Hospital Discharge Disposition After Elective Total Knee Arthroplasty. JAMA Netw Open. 2019;2:e1914259. doi: 10.1001/jamanetworkopen.2019.14259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.14259</ArticleId><ArticleId IdType="pmc">PMC6824220</ArticleId><ArticleId IdType="pubmed">31664446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780&#x2013;5. doi: 10.2106/JBJS.F.00222.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.F.00222</ArticleId><ArticleId IdType="pubmed">17403800</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh JLM, Chan S, Wong KL, et al. Chemoprophylaxis in addition to mechanical prophylaxis after total knee arthroplasty surgery does not reduce the incidence of venous thromboembolism. Thromb J. 2019;17:9. doi: 10.1186/s12959-019-0200-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-019-0200-1</ArticleId><ArticleId IdType="pmc">PMC6584992</ArticleId><ArticleId IdType="pubmed">31249474</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158:1525&#x2013;31. doi: 10.1001/archinte.158.14.1525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.158.14.1525</ArticleId><ArticleId IdType="pubmed">9679793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert A, Lees M, Steinle T. Clinical burden of venous thromboembolism. Curr Med Res Opin. 2010;26:2465&#x2013;73. doi: 10.1185/03007995.2010.516090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2010.516090</ArticleId><ArticleId IdType="pubmed">20825270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e227S&#x2013;e277S. doi: 10.1378/chest.11-2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2297</ArticleId><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth B, Smeets M, Pedersen AB, et al. Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study. J Thromb Haemost. 2024;22:238&#x2013;48. doi: 10.1016/j.jtha.2023.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.09.033</ArticleId><ArticleId IdType="pubmed">38030547</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amore T, Cozzarelli NF, Sutton R, et al. Low-Dose Enteric-Coated and Chewable Aspirin Are Not Equally Effective in Preventing Venous Thromboembolism in Total Knee and Hip Arthroplasty. J Arthroplasty. 2024;39:S129&#x2013;33. doi: 10.1016/j.arth.2024.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2024.06.023</ArticleId><ArticleId IdType="pubmed">38889809</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsoy D, Giori NJ, Woolson ST. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA. Clin Orthop Relat Res. 2018;476:381&#x2013;7. doi: 10.1007/s11999.0000000000000041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999.0000000000000041</ArticleId><ArticleId IdType="pmc">PMC6259721</ArticleId><ArticleId IdType="pubmed">29529673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H-Y, Wang L, Luo Z-Y, et al. Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial. BMC Musculoskelet Disord. 2019;20:478. doi: 10.1186/s12891-019-2885-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2885-5</ArticleId><ArticleId IdType="pmc">PMC6814971</ArticleId><ArticleId IdType="pubmed">31653221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shohat N, Ludwick L, Sherman MB, et al. Using machine learning to predict venous thromboembolism and major bleeding events following total joint arthroplasty. Sci Rep. 2023;13:2197. doi: 10.1038/s41598-022-26032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26032-1</ArticleId><ArticleId IdType="pmc">PMC9905066</ArticleId><ArticleId IdType="pubmed">36750656</ArticleId></ArticleIdList></Reference><Reference><Citation>Anil U, Kirschner N, Teo GM, et al. Aspirin Thromboprophylaxis Following Primary Total Knee Arthroplasty Is Associated With a Lower Rate of Early Prosthetic Joint Infection Compared With Other Agents. J Arthroplasty. 2023;38:S345&#x2013;9. doi: 10.1016/j.arth.2023.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2023.02.041</ArticleId><ArticleId IdType="pubmed">36828050</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer-Westendorf J, F&#xf6;rster K, Pannach S, et al. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood. 2014;124:955&#x2013;62. doi: 10.1182/blood-2014-03-563577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-03-563577</ArticleId><ArticleId IdType="pmc">PMC4126334</ArticleId><ArticleId IdType="pubmed">24859362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwood MW, Nessel CC, Hellkamp AS, et al. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. J Am Coll Cardiol. 2015;66:2271&#x2013;81. doi: 10.1016/j.jacc.2015.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.09.024</ArticleId><ArticleId IdType="pubmed">26610874</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-W, Chen B, Lin P-C, et al. The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial. J Arthroplasty. 2017;32:801&#x2013;6. doi: 10.1016/j.arth.2016.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.08.020</ArticleId><ArticleId IdType="pubmed">27663190</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Liu J, Lai X, et al. The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty. JCM. 2023;12:1161. doi: 10.3390/jcm12031161.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12031161</ArticleId><ArticleId IdType="pmc">PMC9917433</ArticleId><ArticleId IdType="pubmed">36769808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhu H-L, Shi Z-J, et al. The Application of Thromboelastography in Understanding and Management of Ecchymosis After Total Knee Arthroplasty. J Arthroplasty. 2018;33:3754&#x2013;8. doi: 10.1016/j.arth.2018.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2018.08.024</ArticleId><ArticleId IdType="pubmed">30219266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Qin L, Yang J, et al. Changes in Thromboelastography to Predict Ecchymosis After Knee Arthroplasty: A Promising Guide for the Use of Anticoagulants. Front Surg. 2022;9:871776. doi: 10.3389/fsurg.2022.871776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.871776</ArticleId><ArticleId IdType="pmc">PMC9039049</ArticleId><ArticleId IdType="pubmed">35495763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Zheng X, Jiang H, et al. Risk factors for ecchymosis in patients receiving rivaroxaban for thromboprophylaxis after total knee arthroplasty: a retrospective cohort study. J Clin Pharm Ther. 2021;46:1281&#x2013;7. doi: 10.1111/jcpt.13420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.13420</ArticleId><ArticleId IdType="pubmed">33768580</ArticleId></ArticleIdList></Reference><Reference><Citation>Garfinkel JH, Gladnick BP, Roland N, et al. Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty. J Arthroplasty. 2018;33:533&#x2013;6. doi: 10.1016/j.arth.2017.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2017.08.039</ArticleId><ArticleId IdType="pubmed">28947374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinterwimmer F, Lazic I, Langer S, et al. Prediction of complications and surgery duration in primary TKA with high accuracy using machine learning with arthroplasty-specific data. Knee Surg Sports Traumatol Arthrosc. 2023;31:1323&#x2013;33. doi: 10.1007/s00167-022-06957-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-022-06957-w</ArticleId><ArticleId IdType="pmc">PMC10050062</ArticleId><ArticleId IdType="pubmed">35394135</ArticleId></ArticleIdList></Reference><Reference><Citation>Emara WM, Moez KK, Elkhouly AH. Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res. 2014;8:48&#x2013;53. doi: 10.4103/0259-1162.128908.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.128908</ArticleId><ArticleId IdType="pmc">PMC4173581</ArticleId><ArticleId IdType="pubmed">25886103</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant AL, Letson HL, Morris JL, et al. Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study. J Orthop Surg Res. 2018;13:149. doi: 10.1186/s13018-018-0855-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-018-0855-5</ArticleId><ArticleId IdType="pmc">PMC6006687</ArticleId><ArticleId IdType="pubmed">29914535</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar CM, Laffan MA. Drug therapy in anticoagulation: which drug for which patient? Clin Med (Lond) 2017;17:233&#x2013;44. doi: 10.7861/clinmedicine.17-3-233.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.17-3-233</ArticleId><ArticleId IdType="pmc">PMC6297571</ArticleId><ArticleId IdType="pubmed">28572224</ArticleId></ArticleIdList></Reference><Reference><Citation>Za P, Papalia GF, Franceschetti E, et al. Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2023;31:4407&#x2013;21. doi: 10.1007/s00167-023-07500-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-023-07500-1</ArticleId><ArticleId IdType="pubmed">37449989</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Ghanem E, Joshi A, et al. Does &#x201c;excessive&#x201d; anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22:24&#x2013;8. doi: 10.1016/j.arth.2007.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2007.03.007</ArticleId><ArticleId IdType="pubmed">17823010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong LM, Kistler KD, Mills R, et al. Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review. Expert Opin Pharmacother. 2012;13:333&#x2013;44. doi: 10.1517/14656566.2012.652087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14656566.2012.652087</ArticleId><ArticleId IdType="pubmed">22220855</ArticleId></ArticleIdList></Reference><Reference><Citation>Yetkin E, Ileri M, Waltenberger J. Ecchymosis: A novel sign in patients with varicose veins. Clin Hemorheol Microcirc. 2018;68:413&#x2013;9. doi: 10.3233/CH-170320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-170320</ArticleId><ArticleId IdType="pubmed">29660929</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Ma J, Huang Q, et al. Comparison of Enoxaparin and Rivaroxaban in Balance of Anti-Fibrinolysis and Anticoagulation Following Primary Total Knee Replacement: A Pilot Study. Med Sci Monit . 2017;23:704&#x2013;11. doi: 10.12659/msm.900059.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.900059</ArticleId><ArticleId IdType="pmc">PMC5312245</ArticleId><ArticleId IdType="pubmed">28174415</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley A, Sanderson E, Granell R, et al. Using multivariable Mendelian randomization to estimate the causal effect of bone mineral density on osteoarthritis risk, independently of body mass index. Int J Epidemiol. 2022;51:1254&#x2013;67. doi: 10.1093/ije/dyab251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab251</ArticleId><ArticleId IdType="pmc">PMC9365636</ArticleId><ArticleId IdType="pubmed">34897459</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen VG, Goff T, Hunsaker BD, et al. The Gilded Clot: Review of Metal-Modulated Platelet Activation, Coagulation, and Fibrinolysis. Int J Mol Sci. 2023;24:3302. doi: 10.3390/ijms24043302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043302</ArticleId><ArticleId IdType="pmc">PMC9966405</ArticleId><ArticleId IdType="pubmed">36834712</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, Wang D, Xu W, et al. Personalized delayed anticoagulation therapy alleviates postoperative bleeding in total knee arthroplasty (TKA) patients. J Exp Orthop. 2024;11:e70074. doi: 10.1002/jeo2.70074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jeo2.70074</ArticleId><ArticleId IdType="pmc">PMC11522910</ArticleId><ArticleId IdType="pubmed">39478686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A-W, Tetzlaff JM, G&#xf8;tzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7586</ArticleId><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu W-J, Gu X-P, Wu X-D, et al. Restrictive Versus Liberal Strategy for Red Blood-Cell Transfusion: A Systematic Review and Meta-Analysis in Orthopaedic Patients. J Bone Joint Surg Am. 2018;100:686&#x2013;95. doi: 10.2106/JBJS.17.00375.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.17.00375</ArticleId><ArticleId IdType="pubmed">29664857</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">21936146</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58:277&#x2013;80. doi: 10.1097/00000542-198303000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-198303000-00016</ArticleId><ArticleId IdType="pubmed">6829965</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228&#x2013;32. doi: 10.1002/ajh.23599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.23599</ArticleId><ArticleId IdType="pubmed">24123050</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S&#x2013;e325S. doi: 10.1378/chest.11-2404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2404</ArticleId><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Young A, Chapman O, Connor C, et al. Thrombosis and cancer. Nat Rev Clin Oncol. 2012;9:437&#x2013;49. doi: 10.1038/nrclinonc.2012.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2012.106</ArticleId><ArticleId IdType="pubmed">22777060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007;21:1&#x2013;11. doi: 10.1016/j.hoc.2006.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hoc.2006.11.004</ArticleId><ArticleId IdType="pubmed">17258114</ArticleId></ArticleIdList></Reference><Reference><Citation>Madurska MJ, Sachse KA, Jansen JO, et al. Fibrinolysis in trauma: a review. Eur J Trauma Emerg Surg . 2018;44:35&#x2013;44. doi: 10.1007/s00068-017-0833-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-017-0833-3</ArticleId><ArticleId IdType="pubmed">28918481</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464&#x2013;74. doi: 10.1038/nrcardio.2015.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.83</ArticleId><ArticleId IdType="pmc">PMC4624298</ArticleId><ArticleId IdType="pubmed">26076949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119:64S&#x2013;94S. doi: 10.1378/chest.119.1_suppl.64s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.119.1_suppl.64s</ArticleId><ArticleId IdType="pubmed">11157643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>